We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Eurogentec Acquires License From OGT to Develop Oligo Microarray Business
News

Eurogentec Acquires License From OGT to Develop Oligo Microarray Business

Eurogentec Acquires License From OGT to Develop Oligo Microarray Business
News

Eurogentec Acquires License From OGT to Develop Oligo Microarray Business

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Eurogentec Acquires License From OGT to Develop Oligo Microarray Business"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Eurogentec S.A. and Oxford Gene Technology have announced the conclusion of a licensing agreement, wherein Eurogentec has acquired a licence to  OGT’s "Southern array patents", the fundamental patents covering the manufacture and use and marketing of oligonucleotide microarrays. The licence will remain valid for the patents’ lifetime.

Commenting on the agreement, Dr. Driss Talibi, DNA Array Product Manager at Eurogentec, said, "We were in contact with OGT at the earliest stage to discuss the successful agreement, which further strengthens our position in the market segment of custom-made oligo-based microarrays."

Jean-Pierre Delwart, CEO at Eurogentec, further added, "The agreement is very important for our genomic oligo business and we believe that this licence will strongly contribute to increase our HTP oligo business."

Dr Mike Evans, Chief Executive of OGT, said, "We are happy to support Eurogentec’s technology by granting this licence."

"We continue to extend our licensing policy whilst expanding our focus on the development of microarray based products and our custom service offering for the life sciences research and diagnostic markets."

Advertisement